Mechanisms of Action of Antimalarials in Inflammation: Induction of Apoptosis in Human Endothelial Cells

Journal of Immunology

Volumn 158, Issue 4, 1997, Pages 1872-1879

  Potvin, Frédéric ^a   Petitclerc, Eric ^b   Marceau, François ^b   Poubelle, Patrice E ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; LIPOPOLYSACCHARIDE;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DIVISION; DRUG EFFECT; FIBROBLAST; HUMAN; IMMUNOLOGY; INFLAMMATION; OSTEOBLAST; PATHOLOGY; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ANTIMALARIALS; APOPTOSIS; CELL DIVISION; CELLS, CULTURED; CHLOROQUINE; ENDOTHELIUM, VASCULAR; FIBROBLASTS; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; OSTEOBLASTS; UMBILICAL VEINS;

EID: 0031568650     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Page, F. 1951. Treatment of lupus erythematosus with mepacrine. Lancet 2:755.
2. Freedman, A., and F. Bach. 1952. Mepacrine and rheumatoid arthritis. Lancet 2:321.
3. Mainland, D., and M. I. Sutcliffe. 1962. Hydroxychloroquine sulfate in rheumatoid arthritis, a six month, double-blind trial. Bull. Rheum. Dis. 13:287.
4. The Canadian Hydroxychloroquine Study Group. 1991. A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. N. Engl. J. Med. 324:150.
5. Sperber, K., H. Quraishi, T. H. Kalb, A. Panja, V. Strecher, and L. Mayer. 1993. Selective regulation of cytokine secretion by hydroxychloroquine inhibition of interleukin-1α (IL-1α) and IL-6 in human monocytes and T cells. J. Rheumatol. 20:803.
6. Salmeron, G., and L. E. Lipsky. 1983. The immunosuppression potential of antimalarials. Am. J. Med. 75:19.
7. Maione, T. E., and R. J. Sharpe. 1990. Development of angiogenesis inhibitors for clinical applications. Trends Pharmacol. Sci. 11:457.
8. Folkman, J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1:27.
9. Healy, A. M., and I. M. Herman. 1992. Preparation of fluorescent fibroblast growth factor: localization in living retinal microvascular endothelial cells. Exp. Eye Res. 55:663.
10. Inyang, A. L., A. Bikfalvi, H. Lu, and G. Tobelem. 1990. Chloroquine's modulation of endothelial cell activity induced with fibroblast growth factor and human serum: effects on mitogenesis, protease production and cell migration. Cell. Biol. Int. Rep. 14:35.
11. Thompson, C. B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456.
12. Mountz, J. D., J. Wu, J. Cheng, and T. Zhou. 1994. Autoimmune disease. A problem of defective apoptosis. Arthritis Rheum. 37:1415.
13. Araki, S., T. Ishida, T. Yamamoto, K. Kaji, and H. Hayashi. 1993. Induction of apoptosis by hemorrhagic snake venom in vascular endothelial cells. Biochem. Biophys. Res. Commun. 190:148.
14. Nakamura, N., Y. Shidara, N. Kawaguchi, C. Azuma, N. Mitsuda, S. Onishi, K. Yamaji, and Y. Wada. 1994. Lupus anticoagulant autoantibody induces apoptosis in umbilical vein endothelial cells: involvement of annexin V. Biochem. Biophys. Res. Commun. 205:1488.
15. Abello, P. A., S. A. Fidler, G. B. Bulkley, and T. G. Buchman. 1994. Antioxidants modulate induction of programmed endothelial cell death (apoptosis) by endotoxin. Arch. Surg. 129:134.
16. Robaye, B., R. Mosselmans, W. Fiers, J. E. Dumont, and P. Galand. 1991. Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. Am. J. Pathol. 138:447.
17. Tsukada, T., K. Eguchi, K. Migita, Y. Kawabe, A. Kawakami, N. Matsuoka, H. Takashima, A. Mizokami, and S. Nagataki. 1995. Transforming growth factor β1 induces apoptotic cell death in cultured human umbilical vein endothelial cells with down-regulated expression of Bcl-2. Biochem. Biophys. Res. Commun. 210: 1076.
18. Araki, S., Y. Shimada, K. Kaji, and H. Hayashi. 1990. Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation. Biochem. Biophys. Res. Commun. 168:1194.
19. Krajewski, S., M. Krajewska, A. Shabaik, H.-G. Wang, S. Irie, L. Fong, and J. C. Reed. 1994. Immunohistochemical analysis of in vitro patterns of Bcl-X expression. Cancer Res. 54:5501.
20. Furukawa, Y., J. Kikuchi, Y. Terui, S. Kitagawa, M. Ohta, Y. Miura, and M. Saito. 1995. Preferential production of interleukin-1β over interleukin-1 receptor antagonist contributes to proliferation and suppression of apoptosis in leukemic cells. Jpn. J. Cancer Res. 86:208.
21. Lichtenstein, A., Y. Tu, C. Fady, R. Vescio, and J. Berenson. 1995. Interleukin-6 inhibits apoptosis of malignant plasma cells. Cell. Immunol. 162:248.
22. Hardin, J., S. MacLeod, I. Grigorieva, R. Chang, B. Barlogie, H. Xiao, and J. Epstein. 1994. Interleukin-6 prevents dexamethasone-induced myeloma cell death. Blood 84:3063.
23. Yonish-Rouach, E., D. Resnitzky, J. Lotem, A. Kimchi, and M. Oren. 1991. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352:345.
24. Pober, J. S., and R. S. Cotran. 1990. Cytokines and endothelial cell biology. Physiol. Rev. 70:427.
25. Norioka, K., M. Hara, A. Kitani, T. Hirose, W. Hirose, M. Harigai, K. Suzuki, M. Kawakami, H. Tabata, M. Kawagoe, and H. Nakamura. 1987. Inhibitory effect of human recombinant interleukin-1α and β on growth of human vascular endothelial cells. Biochem. Biophys. Res. Commun. 145:969.
26. Cozzolino, F., M. Torcia, D. Aldinucci, M. Ziche, F. Almerigogna, D. Bani, and D. M. Stern. 1990. Interleukin-1 is an autocrine regulator of human endothelial cell growth. Proc. Natl. Acad. Sci. USA 87:6487.
27. Marceau, F., J. Grassi, Y. Frobert, C. Bergeron, and P. E. Poubelle. 1992. Effects of experimental conditions on the production of interleukin-1 alpha and -1 beta by human endothelial cells cultured in vitro. Int. J. Immunopharmacol. 14:525.
28. Garfinkel, S., D. S. Haines, S. Brown, J. Wessendorf, D. H. Gillespie, and T. Maciag. 1992. Interleukin-1 alpha mediates an alternative pathway for the antiproliferative action of poly(I.C) on human endothelial cells. J. Biol. Chem. 267:24375.
29. Maier, J. A. M., P. Voulalas, D. Roeder, and T. Maciag. 1990. Extension of life-span of human endothelial cells by an interleukin-1α antisense oligomer. Science 249:1570.
30. Lundberg, C., F. Marceau, R. Huey, and T. E. Hugh. 1986. Anaphylatoxin C5a fails to promote prostacyclin release in cultured endothelial cells from human umbilical veins. Immunopharmacology 12:135.
31. Poubelle, P. E., J. Grassi, P. Pradelles, and F. Marceau. 1990. Pharmacological modulation of interleukin 1 production by cultured endothelial cells from human umbilical veins. Immunopharmacology 19:121.
32. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. In Molecular Cloning: A Laboratory Manual. C. Nolan, ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. E.10-E.15.
33. Singh, L., and K. W. Jones. 1984. The use of heparin as a simple cost effective means of controlling background in nucleic acid hybridization procedures. Nucleic Acids Res. 12:5627.
34. Grassi, J., Y. Frobert, P. Pradelles, F. Chercuitte, D. Gruaz, J.-M. Dayer, and P. E. Poubelle. 1989. Production of monoclonal antibodies against interleukin-1α and -1β: development of two enzyme immunometric assays (EIA) using acetylcholinesterase and their application to biological media. J. Immunol. Methods 123: 193.
35. Grassi, J., C. J. Roberge, Y. Frobert, P. Pradelles, and P. E. Poubelle. 1991. Determination of IL-1α, IL-1β and IL-2 in biological media using specific enzyme immunometric assays. Immunol. Rev. 119:125.
36. Lebel, M., and J. H. Grose. 1986. Abnormal renal prostaglandins production during the evaluation of chronic nephropathy. Am. J. Nephrol. 6:96.
37. Richardson, B. C., N. D. Lalwani, K. J. Johnson, and R. M. Marks. 1994. Fas ligation triggers apoptosis in macrophages but not endothelial cells. Eur. J. Immunol. 2434:2640.
38. Aringer, M., W. Wintersberger, C. W. Steiner, H. Kiener, E. Presterl, U. Jaeger, J. S. Smolen, and W. B. Graninger. 1994. High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic lupus erythematosus. Arthritis Rheum. 37:1423.
39. Cheng, J., T. Zhou, C. Liu, J. P. Shapiro, M. J. Brauer, M. C. Kiefer, P. J. Barr, and J. D. Mountz. 1994. Identification of a soluble form of the fas molecule that protects cells from fas-mediated apoptosis. Science 263:1759.
40. Hogquist, K. A., M. A. Nett, E. R. Unanue, and D. D. Chaplin. 1991. Interleukin-1 is processed and released during apoptosis. Proc. Natl. Acad. Sci. USA 88:8485.
41. Hogquist, K. A., E. R. Unanue, and D. D. Chaplin. 1991. Release of IL-1 from mononuclear phagocytes. J. Immunol. 147:2181.
42. de Vries, P. J., B. Oosterhuis, and C. J. Van Boxtel. 1994. Single-dose pharmacokinetics of chloroquine and its main metabolite in healthy volunteers. Drug Invest. 8:143.
43. Re, F., A. Zanetti, M. Sironi, N. Polentarutti, L. Lanfrancone, E. Dejana, and F. Colotta. 1994. Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells. J. Cell Biol. 127:537.
44. Hirata, S., T. Matsubara, R. Saura, H. Tateishi, and K. Hirohata. 1989. Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low-dose methotrexate. Arthritis Rheum. 32:1065.
45. Tallarida, R. J., and R. B. Murray. 1987. Manual of Pharmacologic Calculations with Computer Programs. Springer, New York.